72
XING, L; SCHWARZ, EM & BOYCE, BF. Osteoclast precursors, RANKL/RANK, and
immunology. Immunological reviews, 208, 19-29, 2005.
YAMASAKI, M; KUMAZAWA, M; KOHSAKA, T & NAKAMURA, H. Effect of
methotrexate-induced neutropenia on rat periapical lesion. Oral surgery, oral
medicine, and oral pathology, 77, 655-661, 1994.
YANG, YF; MUKAI, T; GAO, P; YAMAGUCHI, N; ONO, S; IWAKI, H; OBIKA, S;
IMANISHI, T; TSUJIMURA, T; HAMAOKA, T & FUJIWARA, H. A non-peptide CCR5
antagonist inhibits collagen-induced arthritis by modulating T cell migration without
affecting anti-collagen T cell responses. European journal of immunology, 32,
2124-2132, 2002.
YASUDA, H; SHIMA, N; NAKAGAWA, N; YAMAGUCHI, K; KINOSAKI, M;
MOCHIZUKI, S; TOMOYASU, A; YANO, K; GOTO, M; MURAKAMI, A; TSUDA, E;
MORINAGA, T; HIGASHIO, K; UDAGAWA, N; TAKAHASHI, N & SUDA, T.
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-
inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National
Academy of Sciences of the United States of America, 95, 3597-3602, 1998.
YU, X; HUANG, Y; COLLIN-OSDOBY, P & OSDOBY, P. CCR1 chemokines promote
the chemotactic recruitment, RANKL development, and motility of osteoclasts and
are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res, 19, 2065-
2077, 2004.
YU, X; HUANG, Y; COLLIN-OSDOBY, P & OSDOBY, P. Stromal cell-derived factor-1
(SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix
metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J Bone Miner
Res, 18, 1404-1418, 2003.
YUAN, GH; MASUKO-HONGO, K; SAKATA, M; TSURUHA, J; ONUMA, H;
NAKAMURA, H; AOKI, H; KATO, T & NISHIOKA, K. The role of C-C chemokines and
their receptors in osteoarthritis. Arthritis and rheumatism, 44, 1056-1070, 2001.